A REPORT ON RATIO ANALYSIS OF GLAXOSMITHKLINE
[GSK PHARMACEUTICALS]Financial Management
COURSE: INTRODUCTION TO BUSINESS FINANCE
TEACHER: SIR MIRZA SIKANDER TAJ
PREPARED BY: SYED ADNAN SHAH SALEEM
REG # 53128
2012 [GSK CONSUMER HEALTHCARE]
Amrita School of Business 2
2012 [GSK CONSUMER HEALTHCARE]
FINANCIAL RATIOS
LIQUIDITY RATIO:
Liquidity ratios are calculated to measure the short term financial soundness of
the business. The ratios assess the capacity of the company to repay its short
term liability. Banks and other money lenders for short period are interested in
the current assets of the company i.e. short term financial position of the
business. The important liquidity ratios are: current ratio, acid-test ratio and
cash ratio.
1. CURRENT RATIO:
This is a popular ratio which expresses the relationship between current assets
and current liabilities. The current ratio is a popular ratio, and it can be
expressed as
Current assets include cash, current investments, debtors, inventories, loans
and advances and prepaid expenses. Current Liabilities represent liabilities that
are expected to mature in the next twelve months. These comprise (1) loans,
secured or unsecured, that are due in the next twelve months and (2) current
liabilities and provisions.
Amrita School of Business 3
Current Ratio = Current Assets / Current Liabilities
2012 [GSK CONSUMER HEALTHCARE]
2011
(In Cr.)
2010
(In Cr.)
2009
(In Cr.)
2008
(In Cr.)
2007
(In Cr.)
Total Current Assets (A) 932.92 771.90 808.84 864.78 755.42
Total Current Liabilities (B) 810.46 682.68 589.91 610.84 569.97
Current Ratio (A/B) 1.15 1.13 1.37 1.42 1.33
Analysis:
The current ratio of the company is currently at 1.15 which is a good sign; it
implies that for every one rupee of liabilities the firm has Rs. 1.15 assets. But
the share of inventories is 18.8 % of the total current assets in 2010, lower
than the previous year which was at 16.2 % and the cause for current ratio to
drop from 1.37 (2009) to 1.13 (2010) is the increase in current liabilities.
2. QUICK RATIO:
Quick ratio is also known as “Acid Test Ratio” Historically this ratio is regarded
as a good indicator of liquidity. Quick Ratio refers to those current assets which
can be converted into cash quickly. They include all Current assets except
inventories or stock which are not sufficiently liquid.
Amrita School of Business 4
Quick ratio = Quick Assets/ Current Liabilities
Or
Quick ratio = Current assets – (Inventory) / Current Liabilities
2012 [GSK CONSUMER HEALTHCARE]
2011 2010 2009 2008 2007
Total Current Assets 932.92 771.90 808.84 864.78 755.42
Inventories 194.82 145.57 131.04 85.17 92.33
CA – Inventories (A) 738.10 626.33 677.80 779.61 663.09
Total Current Liabilities (B) 810.46 682.68 589.91 610.84 569.97
Quick Ratio (A/B) 0.91 0.92 1.15 1.28 1.16
Analysis:
The acid test ratio is ideally 1:1 or better i.e. the ratio should be greater than or
equal to one. But since the current ratio industrial average is less than 1,
therefore the industrial quick ratio average is estimated to be below 1. Hence a
quick ratio of the company is quite good indicating a healthy liquidity position
of the company.
TURNOVER RATIOS:
Turnover ratios are referred to as activity ratios or asset management ratios,
measures how efficiently the assets are employed by a firm. These ratios are
based on the relationship between the level of activity, represented by sales or
cost of goods sold, and various levels of assets. The important turnover ratios
are: inventory turnover, average collection period, receivables turnover, fixed
assets turnover, and total assets turnover.
Amrita School of Business 5
2012 [GSK CONSUMER HEALTHCARE]
1. INVENTORY TURNOVER RATIO:
The inventory turnover, or stock turnover, measures how fast the inventory is
moving through the firm and generating sales. It is defined as:
The inventory turnover reflects the efficiency of inventory management. The
higher the ratio, the more efficient the management of inventories and vice
versa. However, this may not always be true. A high inventory turnover may be
caused by a low level of inventory which may result in frequent stock outs and
loss of sales and customer goodwill.
2011 2010 2009 2008 2011
Net Sales 1273 1109 965 861 780
Gross Profit 520 473 388 350 311
COGS (A) 753 636 577 512 485
Inventory 194.8 145.6 131.04 85.17 92.33
Average Inventory (B) 170.2 138.32 108.1 88.8 89.1
Inventory Turnover Ratio
(A/B)
4.42 4.59 5.33 5.76 5.45
Amrita School of Business 6
Inventory Turnover Ratio = COGS / Average Inventory
2012 [GSK CONSUMER HEALTHCARE]
Analysis:
The Inventory Turnover Ratio has not improved from the previous year
indicating that the company has increased its blocked inventory. The average
inventories in 2011 have increased by 23.15% from 2010 and by 27.9% from
the previous year but the Cost of Goods Sold has grown at 18.3% this year. This
ratio has been steadily coming down over the past 5 years indicating a stable
efficient management. A low ratio implies either low sales or an increase in
inventory. For the company this ratio has decreased due to increase in
inventory.
2. FIXED ASSET TURNOVER RATIO:
Fixed Assets are used in the business for producing goods to be sold. The
effective utilization of Fixed Assets will result in increased production and
reduced cost. It also ensures whether the investment in the assets have been
judicious or not. Higher ratio indicates better performance. The ratio is very
significant for manufacturing enterprises, where fixed assets employed are
more than working capital.
Amrita School of Business 7
Fixed Assets Turnover Ratio = Net Sales/ Fixed Assets
2012 [GSK CONSUMER HEALTHCARE]
2011 2010 2009 2008 2011
Net Sales (A) 1273 1109 965 861 780
Net Block (Fixed Assets) (B) 226 251 272.9 300.1 323.5
Fixed Assets Turnover
Ratio (A/B)
5.63 4.41 3.53 2.86 2.41
Analysis:
An ideal Fixed Asset Turnover Ratio for any company is 5:1. GSK-CH has
maintained this ratio well above the ideal value indicating that it generates
Rs. 5.63 from every 1 Re of its fixed assets. It could be due to the depreciation
charged on the gross block, due to which the net block is a lower value which
in turn increases this ratio. This ratio shows an upward moving trend on
analysis.
3. DEBTORS TURNOVER RATIO:
Debtor turnover ratio indicates the number of times the debtors are turned
during the year. This ratio is calculated with the Net sales over the Average
debtor. Debtor turnover ratio indicates the number of times the debts are
collected in a year.
Amrita School of Business 8
Debtor turnover Ratio = Net sales / Average Debtors
2012 [GSK CONSUMER HEALTHCARE]
2011 2010 2009 2008 2011
Net Sales (A) 1273 1109 965 861 780
Sundry Debtors 27.3 28.1 24.1 25.2 18.3
Average Sundry Debtors (B) 27.7 26.1 24.6 21.75 31.3
Debtors Turnover Ratio
(A/B)
45.9 42.5 39.2 39.5 24.9
Analysis:
The DTR ratio for GSK has increased from the previous years indicating that its
ability to turn debtors to cash has increased and has maintained similar rates
over the years. This ratio is very close to the industrial average.
4. AVERAGE COLLECTION PERIOD (ACP):
The average collection period represents the number of day’s worth of credit
sales that is locked in sundry debtors. Shorter the average collection period the
better is the ratio and higher is the liquidity.
Amrita School of Business 9
Average Collection Period = 365/Debtors Turnover
Or
Average Collection Period= Average Sundry Debtors / Average daily credit sales
2012 [GSK CONSUMER HEALTHCARE]
2011 2010 2009 2008 2011
Average Collection Period 8 9 9 9 15
Analysis:
Since GSK has a high DTR its Average Collection Period is lower i.e. it has
reduced the time for which credit sales is outstanding. This ratio gives a
positive indication about the company revenue collections. ACP decreased
from 15days in 2011 to 9 days in 2008 and had been the same for some years
and decreased further to 8.The Company is quite healthy.
5. TOTAL ASSETS TURNOVER RATIO (TATR):
The ratio establishes the relationship between net sales and total assets of the
firm. It shows in what proportion the total assets of the firm have contributed
to the sales.
2011 2010 2009 2008 2011
Net Sales (A) 1273 1109 965 861 780
Total Assets 646.3 542.7 475.1 529.3 492.1
Average Total Assets (B) 594.5 508.9 502.2 510.7 487.6
Amrita School of Business 10
Total Assets Turnover Ratio = Net Sales / Average Total Assets
2012 [GSK CONSUMER HEALTHCARE]
T.A.T.R (A/B) 2.14 2.17 1.92 1.68 1.59
Analysis:
A TATR of 2.14 indicates that the company can generate net sales 2.14 times
its total asset value, i.e. for every one rupee of total assets the company
generates Rs.2.14. The company had shown a steady increase in the ratio for
the last five years.
PROFITABILITY RATIO:
Profitability reflects the final results of business operations. Profitability ratios
are the ratios which measure the profitability of a concern. In other words,
they are the ratios which reveal the total effect of the business transactions on
the profit position of an enterprise and indicate how far the enterprise has
been successful in its aim and how far it has achieved its objectives. There are
two types of profitability ratios: profit margin ratios and rate of return ratios.
Profit margin ratios show the relationship between profit and sales. The most
popular profit margin ratios are: Gross Profit Margin, Operating Profit Margin
and Net Profit margin. Rate of return ratios reflect the relationships between
profit and investment. The most popular rate of return measures are: Return
on Assets, Earning Power, Return on Capital Employed and Return on Equity.
1. GROSS PROFIT MARGIN (GPM):
Amrita School of Business 11
2012 [GSK CONSUMER HEALTHCARE]
It shows the relationship between the gross profit and sales. This ratio shows
the margin of profits on sales. This ratio measures the efficiency of production
and pricing. This ratio indicates the margin left after meeting manufacturing
costs.
2011 2010 2009 2008 2011
Gross Profit (A) 520 473 388 350 311
Net Sales (B) 1273 1109 965 862 796
G.P.M (A/B)40.84% 42.65% 40.20% 40.6% 39.07%
Analysis:
A GPM of 40.84% indicates that the company has 40.84% of sales remaining
after meeting its operating costs. This ratio is showed a decline in the present
year 07 from 42% in the previous year. The decline of GPM in FY07 can be
attributed to the increase in cost of raw materials without an equally
significant increase in net sales. However the company has worked hard to
maintain its margin at around 40% for the last few years which is really good
sign.
2. NET PROFIT MARGIN (NPM):
The ratio establishes relationship between net profit and net sales. Net profit
or the Net income is the gross profit less selling, distribution and financial
Amrita School of Business 12
Gross Profit Margin = (Gross Profit / Net sales) * 100
2012 [GSK CONSUMER HEALTHCARE]
expenses. This ratio indicates earnings left for preference and equity
shareholders as a percentage of net sales. It measures the overall efficiency of
production, administration, financing, pricing and tax management.
2011 2010 2009 2008 2011
Reported Net Profit (PAT) (A) 163 127 107 73 76
Net Sales (B) 1273 1109 965 862 796
N.P.M (A/B) 12.80% 11.45% 11.08% 8.47% 9.55%
Analysis:
The NPM has increased from FY03 to FY07 except for the FY04. A NPM of
12.8% indicates that the company has 12.8% of its net sales revenue remaining
for its owners. Higher the ratio indicates greater utilization of its resources and
better returns to its owners.
3. RETURN ON CAPITAL EMPLOYED (ROCE):
This is one of the most important ratios for the measure of overall profitability.
It indicates the relationship of net profit with capital employed in the business.
Here for calculating return on investment will mean the net profit before
interest, tax and dividend.Net profit means net profit of the year excluding
undivided profit and reserves. ROCE is post-tax version of earning power. It
Amrita School of Business 13
Net Profit Margin = (Net Profit / Net Sales) * 100
2012 [GSK CONSUMER HEALTHCARE]
considers the effect of taxation, but not the capital structure. It is internally
consistent. Its merit is that it is defined in such a way that it can be compared
directly with the post-tax weighted average cost of capital of the firm.
2011 2010 2009 2008 2011
Tax 84 62 55 39 31
PBT (1) 245 191 162 116 100
Interest (2) 5 4 4 5 5
PBIT (1+2) 250 195 166 121 105
PBIT(1-T) (A) 165 129 110 80 69
Average Total Assets (B) 595 509 502 511 488
ROCE (A/B) 27.73% 25.34% 21.91% 15.66% 14.13%
Analysis:
The ROCE of the company increased to 27.73% from the previous year’s value
of 25.34%. This ratio indicates that the company made a return of 27.73% with
the capital it has employed. A higher value is a good indication for the
company.
4. RETURN ON EQUITY (ROE):
Amrita School of Business 14
ROCE = (PBIT (1-T) / Average Total Assets) * 100
2012 [GSK CONSUMER HEALTHCARE]
This ratio measures the profitability of the capital invested in the business by
equity shareholders. As the business is conducted with a view to earn profit,
return on equity capital measures the business success and managerial
efficiency. This ratio is also called the return on net worth .It measures the
productivity of risk capital.
2011 2010 2009 2008 2011
Equity Earnings (PAT) (A) 162.68 126.93 107.15 73.16 76.35
Total Shareholders Funds (B) 646.35 542.72 475.11 529.35 492.11
Return on Equity (A/B) 27.3% 23.38% 22.55% 13.82% 15.51%
Analysis:
This ratio indicates the company has made a profit of 25.16% from the equity
earnings invested in the firm. The ROE fell by about 10.8% in FY04 due
reduction in net profits and an increase in shareholders’ funds. The decrease
during FY04 was followed by increase in ROE in the next three years. The
increase in ROE was due to increased gross profits. Since the equity returns
have increased it is good from the shareholders point of view.
5. Return on Investment (ROI):
Amrita School of Business 15
Return on Equity = Equity Earnings / Average Net Worth
2012 [GSK CONSUMER HEALTHCARE]
This ratio show the return on the investment made in the company. Every
Investor would like to have a higher return on the investment made in the
company. It is also called as earning power. Earning power is a measure of
business performance which is not affected by interest charges and tax
burden. It abstracts away the effect of capital structure and tax factor and
focuses on operating performance. It is eminently suited for inter-firm
comparison. It is internally consistent.
2011 2010 2009 2008 2011
PBT (1) 245 191 162 116 100
Interest (2) 5 4 4 5 5
PBIT (1+2) (A) 250 195 166 121 105
Average Total Assets (B) 594.5 508.9 502.2 510.7 487.6
ROI (A/B) 42% 38.3% 33.1% 23.7% 21.5%
Analysis:
This ratio indicates that the company has made a profit of 42% on the total
investments. This ratio has not been stable over the past five years. This
fluctuation was due the disparity in the changes of raw materials, sales and
acquisition of assets. However the matter of paramount importance is that
there is increase in ROI steadily.
Amrita School of Business 16
ROI = (PBIT / Average Total Assets) *100
2012 [GSK CONSUMER HEALTHCARE]
6. Return on Assets (ROA):
This ratio measures the efficiency of capital employed. Both the numerator and
denominator are internally inconsistent.
2011 2010 2009 2008 2011
PAT (A) 162.68 126.93 107.15 73.16 76.35
Average Total Assets (B) 594.5 508.9 502.2 510.7 487.6
Return on Assets (A/B) 27.3% 24.9% 21.3% 14.3% 15.6%
Analysis:
This ratio indicates the company has made a net profit of 27.3% from the total
assets it has employed. The higher the value of ROA the better, because the
company is earning more money on its assets. The company is showing an
increasing trend in ROA which is clearly evident from the table provided above.
These are promising signs for the future.
LEVERAGE RATIOS:
Financial leverage refers to the use of debt finance. Leverage ratios help in
assessing the risk arising from the use of debt capital. Two types of ratios are
Amrita School of Business 17
Return on Assets=Net Profit after Tax/Average Total Assets
2012 [GSK CONSUMER HEALTHCARE]
commonly used to analyze financial leverage: structural ratios and coverage
ratios. Structural ratios are based on the proportions of debt and equity in
the financial structure of the firm. The important structural ratios are: debt-
equity ratio and debt-assets ratio. Coverage ratios show the relationship
between debt servicing commitments and the sources for meeting these
burdens. The most important coverage ratios are: interest coverage ratio
fixed charges coverage ratio and debt service coverage ratio.
1. DEBT EQUITY RATIO:
This expresses the relationship between debt and equity of the firm. It shows
the relative contribution of creditors and owners. The lower the Debt Equity
Ratio greater the protection for creditors. This ratio does not reflect the
market value of equity or the current value of asset.
2011 2010 2009 2008 2011
Total Debt (A) 0 0 0 0 0
Share Capital (a) 42 42 42 45.4 45.4
Reserves Total (b) 604 501 433 483 447
Total Shareholders’ funds
( a + b ) (B) 646 543 475 528.4 492.4
D/E (A/B) 0 0 0 0 0
Amrita School of Business 18
Debt Equity Ratio= Debt/ Equity
2012 [GSK CONSUMER HEALTHCARE]
Analysis:
This ratio indicates that the total debt raised by the company is 0. The lower
this ratio indicates higher degree of protection by the creditors. This value has
remained the same for the previous years indicating a higher level of security
for the outsiders of the company. The lower the ratio the better it is for the
shareholders of the company, this is because a) A higher value would mean
higher debt which implies increased interest payments resulting in lower
returns and b) The investor would be the last person to receive any
money in case the company is liquidated and the higher the debt the
lower this amount would be.
2. INTEREST COVERAGE RATIO:
It is also called the times interest earned, the ratio is expressed as
A high interest coverage ratio means that the firm can easily meet its burden
even if profit before interest and tax suffer a considerable decline. A low
interest coverage ratio may result in financial embarrassment when
earnings before and taxes decline. This ratio is widely used by lenders to
assess a firm’s debt capacity. It is a major determinant of bond rating. This
ratio measures the margin of safety with reference to interest payment.
2011 2010 2009 2008 2011
Amrita School of Business 19
Interest Coverage Ratio=PBIT/Interest
2012 [GSK CONSUMER HEALTHCARE]
Profit before Tax (1) 245 191 162 116 100
Interest (2) 5 4 4 5 5
PBIT (1+2) (B) 250 195 166 121 105
Interest (A) 5 4 4 5 5
ICR (B/A) 50 48.75 41.75 24.2 21
Analysis:
The higher the Interest Coverage Ratio the better for the company since it
measure the interest paying capacity of the company on its debt. This
ratio has gone up for the company during the last five years due to lower or
zero total debts (both secured and unsecured loans) and hence no interest
payable.
3. Debt Asset Ratio:
The ratio measures the extent to which borrowed funds support the firm’s
assets. Lower this ratio lesser is the leverage and lesser is the risk.
2011 2010 2009 2008 2011
Total Debts (A) 0 0 0 0 0
Total Assets (B) 1159 1023 1082 1165 1079Amrita School of Business 20
Debt Ratio= Debt/Assets
2012 [GSK CONSUMER HEALTHCARE]
Debt/asset ratio (A/B) 0 0 0 0 0
Analysis:
This ratio shows the relation between total debt and total assets. This ratio
also shows the same trend. This is mainly due to no debt raised by the firm.
VALUATION RATIOS:
Valuation ratios indicate how the equity stock of the company is assessed in
the capital market. Since the market value of equity reflects the combined
influence of risk and return, valuation ratios are the most comprehensive
measures of a firm’s performance. The important valuation ratios are: price-
earnings ratio, EV-EBITDA ratio, and market value to book ratio.
1. Earnings per Share:
It helps to determine the market price of the company. A higher EPS indicates
that the Market Value of Equity Shares will be higher.
2011 2010 2009 2008 2011
Amrita School of Business 21
E P S = (Net Profit- Preference Dividend)/ Equity Share holders
2012 [GSK CONSUMER HEALTHCARE]
Reported Net Profit- PAT (A) 162.68 126.93 107.15 73.16 76.35
No of equity shareholders (B) 4.2 4.2 4.2 4.54 4.54
EPS (A/B) 38.73 30.22 25.51 16.11 16.82
Analysis:
The EPS of GSK has gone up due to higher net profits .Net Profits improved by
28.16% in 2011, resulting in a 28.16% increase in EPS. The higher the EPS the
better is the company’s performance. It is to be noted that the increase in PAT
and EPS in percentage terms is the same due to zero debt and zero preference
dividend.
2. Price-earnings Ratio (P/E ratio):
The price-earnings ratio is a summary measure which primarily reflects the
following factors: growth prospects, risk characteristics, shareholder
orientation, corporate image and the degree of liquidity. It reflects price per
rupee of earning. Higher the ratio higher are the expectation of growth rate,
dividend payout etc.
2011 2010 2009 2008 2011
MPS (52 week Average) 651.7 547 445 325.6 292.83
Amrita School of Business 22
P/E Ratio =Market price per share/Earnings per share
2012 [GSK CONSUMER HEALTHCARE]
EPS (B) 38.73 30.22 25.51 16.11 16.82
P/E Ratio (A/B) 16.83 18.1 17.44 20.21 17.4
Analysis:
The P/E ratio indicates how many years it will take to get back the value
invested in one share if the same EPS and MPS are maintained. The P/E ratio of
GSK indicates that it will take 16.83 years to get back the money invested. The
P/E ratio showed a decline from 2010 to 2011. The P/E has shown a mixed
trend from 2011 to 2011 i.e. an intermittent increase and decrease. The P/E
ratio is as indication of market expectations of the returns. A very high value
would imply that the share value is overvalued and possess increased
speculation.
3. Market Value to Book Value Ratio:
This ratio reflects the contribution of a firm to the wealth of society.
2011 2010 2009 2008 2011
MPS (52 week Average) 651.7 547 445 325.6 292.83
Book Value (B) 153.67 129.03 112.96 116.65 108.44
Market to book value (A/B) 4.24 4.23 3.94 2.79 2.7
Analysis: Amrita School of Business 23
Market to Book Value Ratio=Market Value per Share/Book Value per Share
2012 [GSK CONSUMER HEALTHCARE]
A Market Value to Book Value Ratio of greater than one indicates that
the firm has contributed to the wealth of the society. A ratio of less than 1
indicates that the firm has detracted wealth from the society. GSK has
contributed wealth to the society in the past four years. For FY07 this ratio is
4.24 which means that for every Rs. 1 invested by the society the firm has
returned Rs 4.24. The MPS is the major influencing factor in determination
of this ratio, i.e. the expectations of the market. This ratio indicates by what
factor the market expectations exceed the book value of the company. A value
of above 1 indicates higher market expectations.
4. Dividend per Share:
This ratio is a better indicator of company' s performance when compared
to EPS as it shows what exactly owners are entitled to receive on a per share
basis.
2011 2010 2009 2008 2011
Dividend (A) 50.47 42.06 33.64 31.77 31.77
No of equity shareholders (B) 4.2 4.2 4.2 4.54 4.54
DPS (A/B) 12.02 10.01 8.01 6.99 6.99
Analysis:
The dividend per share for FY07 is 12.02, which is higher than the previous
year’s value, it indicates that the company has given increased returns to its Amrita School of Business 24
Dividend per Share = Equity Dividend/ Total Equity Shares
2012 [GSK CONSUMER HEALTHCARE]
shareholders, higher the DPS value the better it is for the shareholders. The
DPS remained the same in 2011-04 periods and then increased 14.5% to 8.01.
Then it increased by 20.07% in the current year.
5. Dividend Yield:
A financial ratio that shows how much a company pays out in dividends each
year relative to its share price. In the absence of any capital gains, the dividend
yield is the return on investment for a stock. Dividend yield is a way to
measure how much cash flow you are getting for each rupee invested in
equity.
2011 2010 2009 2008 2011
DPS 12.02 10.01 8.01 6.99 6.99
MPS (52 week average) 651.7 547 445 325.6 292.83
Dividend yield 1.84% 1.83% 1.8% 2.1% 2.4%
Analysis:
The Dividend Yield remained the same for the last 3 years at 1.8%. However it
fell from 2.1% to 1.8% in 2009. This is due to an increase in the 52 week
average market price of the company and buyback of shares by the firm. The
company has a significant improvement in the payment of dividends. The
Amrita School of Business 25
Dividend Yield = (DPS/ Price) * 100
2012 [GSK CONSUMER HEALTHCARE]
investor should look into the dividend yield also for making the investment
decisions, since it implies the annual returns from the company.
KEY RATIOS
2011
Liquidity RatiosCR 1.15
Quick Ratio 0.91
Leverage RatiosDebt Equity 0Debt Asset 0
Interest coverage 50
Profitability RatiosGross Profit 40.84Net profit 12.8
Return on Assets 27.3Return on Capital Employed 27.73
Return on Equity 27.3Return on Investment 42
Turnover Ratios
Amrita School of Business 26
2012 [GSK CONSUMER HEALTHCARE]
Inventory Turnover 4.42Fixed Asset Turnover 5.63Total Asset Turnover 2.14
Debtors Turnover 45.9Average Collection Period 8
MPS (52 week Avg) 651.7
Valuation RatiosP/E Ratio (A/B) 16.83
Market To Book Value (A/B) 4.24DPS 12.02
Dividend Yield 1.84EPS 38.73
INDUSTRIAL AVERAGE
Amrita School of Business 27
2012 [GSK CONSUMER HEALTHCARE]
DU PONT ANALYSIS
*
* Amrita School of Business 28
Return on Equity27.3
ROTA 27.3
Total assets/ Equity 1
Net Profit Margin 12.8
Total assets Turnover 2.14
Net Profit 163
Net Sales 1273
Net Sales 1273
Total Assets 594.5
Net Sales 1273
Total Costs 1110
Fixed Assets 226
Current Assets 368.5
2012 [GSK CONSUMER HEALTHCARE]
/ /
- +
BALANCE SHEET
Year Dec 07 Dec 06 Dec 05 Dec 04 Dec 03 SOURCES OF FUNDS : Share Capital + 42.06 42.06 42.06 45.38 45.38 Reserves Total + 604.29 500.66 433.05 483.97 446.73 Total Shareholders Funds 646.35 542.72 475.11 529.35 492.11 Secured Loans + 0 0 0 0 0 Unsecured Loans + 0 0 0 0 0 Total Debt 0 0 0 0 0 Total Liabilities 646.35 542.72 475.11 529.35 492.11 APPLICATION OF FUNDS : Gross Block + 523.67 521.69 506.91 497.33 485.86 Less : Accumulated Depreciation + 297.65 270.32 233.95 197.24 162.31 Net Block + 226.02 251.37 272.96 300.09 323.55
Amrita School of Business 29
2012 [GSK CONSUMER HEALTHCARE]
Lease Adjustment 0 0 0 0 0 Capital Work in Progress+ 17.31 6.52 10.83 7.3 6.36 Investments + 297.84 219.68 0 0 0 Current Assets, Loans & Advances Inventories + 194.82 145.57 131.04 85.17 92.33 Sundry Debtors + 27.36 28.09 24.11 25.22 18.38 Cash and Bank+ 93.67 47.92 185.8 264.47 203.8 Loans and Advances + 617.07 550.32 467.89 489.92 440.91 Total Current Assets 932.92 771.9 808.84 864.78 755.42 Less : Current Liabilities and Provisions Current Liabilities + 220.31 188.23 176.58 169.69 169.11 Provisions + 590.15 494.45 413.33 441.15 400.86 Total Current Liabilities 810.46 682.68 589.91 610.84 569.97 Net Current Assets 122.46 89.22 218.93 253.94 185.45 Miscellaneous Expenses not written off + 0 0 0 0 4.91 Deferred Tax Assets 6.07 4.58 5.29 6.57 6.66 Deferred Tax Liability 23.35 28.65 32.9 38.55 34.82 Net Deferred Tax -17.28 -24.07 -27.61 -31.98 -28.16 Total Assets 646.35 542.72 475.11 529.35 492.11 Contingent Liabilities+ 0 0 27.51 22.27 20.57
PROFIT AND LOSS ACCOUNT
YearDec 07(12)
Dec 06(12)
Dec 05(12)
Dec 04(12)
Dec 03(12)
INCOME : Sales Turnover + 1,395.51 1,210.19 1,089.02 981.72 908.95 Excise Duty 122.09 101.34 124.43 120.19 113.07 Net Sales 1,273.42 1,108.85 964.59 861.53 795.88 Other Income + 68.86 58.16 49.12 48.48 51.53 Stock Adjustments + 27.34 1.44 38.1 -5.81 4.77
Total Income 1,369.62 1,168.451,051.8
1 904.2 852.18 EXPENDITURE : Raw Materials + 347.66 275.05 251.86 224.26 205.27 Power & Fuel Cost+ 30.44 29.93 27.35 24.85 23.52 Employee Cost + 149.99 130.35 115.24 103.64 97.16 Other Manufacturing Expenses + 189.7 172.7 157.01 129.18 125.91
Amrita School of Business 30
2012 [GSK CONSUMER HEALTHCARE]
Selling and Administration Expenses + 322.78 296.42 265.52 229.63 217.34 Miscellaneous Expenses + 35.83 27.19 26.34 30.25 32.83 Less: Pre-operative Expenses Capitalised+ 0 0 0 0 0 Total Expenditure 1,076.40 931.64 843.32 741.81 702.03 Operating Profit 293.22 236.81 208.49 162.39 150.15 Interest + 4.61 3.53 4.22 5.25 4.99 Gross Profit 288.61 233.28 204.27 157.14 145.16 Depreciation+ 43.49 42.71 41.85 41.46 45.58 Profit Before Tax 245.12 190.57 162.42 115.68 99.58 Tax+ 84.48 62.13 55.49 38.7 30.7 Deferred Tax+ -6.79 -3.53 -4.38 3.82 -7.47 Reported Net Profit 162.68 126.93 107.15 73.16 76.35 Extraordinary Items + 0.12 -0.24 -0.28 -0.01 -0.06 Adjusted Net Profit 162.56 127.17 107.43 73.17 76.41 Adjst. below Net Profit + 0 0 0 0 0 P & L Balance brought forward 0 0 0 0 0 Statutory Appropriations + 0 0 0 0 0 Appropriations + 162.68 126.93 107.15 73.16 76.35 P & L Balance carried down 0 0 0 0 0 Dividend 50.47 42.06 33.64 31.77 31.77 Preference Dividend 0 0 0 0 0 Equity Dividend % 120 100 80 70 70 Earnings Per Share-Unit Curr 36.64 28.78 24.35 15.21 15.93 Book Value-Unit Curr 153.67 129.03 112.96 116.65 108.44
Common Base Year Financial Statements
Balance Sheet
Year 2011 2010 2009 2002 SOURCES OF FUNDS : Share Capital + 92.68 92.68 92.68 100 Reserves Total + 138.02 114.34 98.91 100 Total Shareholders Funds 133.76 112.31 98.32 100 Secured Loans + 100 100 100 100 Unsecured Loans + 100 100 100 100 Total Debt 100 100 100 100 Total Liabilities 133.76 112.31 100 100 APPLICATION OF FUNDS : Gross Block + 112.12 101.73 98.86 100
Amrita School of Business 31
2012 [GSK CONSUMER HEALTHCARE]
Less : Accumulated Depreciation + 242.58 220.31 190.67 100 Net Block + 57.93 64.43 69.97 100 Lease Adjustment 100 100 100 100 Capital Work in Progress+ 627.17 236.23 392.39 100 Investments + 297.84 219.68 100 100 Current Assets, Loans & Advances Inventories + 226.32 169.11 152.23 100 Sundry Debtors + 61.73 63.38 54.39 100 Cash and Bank+ 93.87 48.02 186.19 100 Loans and Advances + 975.75 870.21 739.86 100 Total Current Assets 317.94 263.06 275.65 100 Less : Current Liabilities and Provisions 100 Current Liabilities + 129.66 110.78 103.92 100 Provisions + 8018.34 6718.07 5615.89 100 Total Current Liabilities 457.16 385.08 332.76 100 Net Current Assets 105.43 76.81 188.49 100 Miscellaneous Expenses not written off + 0 0 0 100 Deferred Tax Assets 121.4 91.6 105.8 100 Deferred Tax Liability 57.47 70.51 80.97 100 Net Deferred Tax 48.49 67.56 77.49 100 Total Assets 133.75 112.31 98.32 100 Contingent Liabilities+ 0 0 5502 100
Profit and Loss Account
particulars / year 2011 2010 2009 2002 INCOME : Sales Turnover + 60.21 38.93 25.02 100 Excise Duty 3.4 -14.17 5.39 100 Net Sales 69.12 47.26 28.1 100 Other Income + 36.41 15.21 -2.69 100 Stock Adjustments + 403.5 -73.48 601.66 100 Total Income 69.32 44.45 30.03 100 EXPENDITURE : Raw Materials + 88.98 49.52 36.91 100 Power & Fuel Cost+ 53.58 51.01 37.99 100 Employee Cost + 52.22 34.02 18.49 100
Amrita School of Business 32
2012 [GSK CONSUMER HEALTHCARE]
Other Manufacturing Expenses + 74.69 59.04 44.59 100 Selling and Administration Expenses + 63.19 49.86 34.24 100 Miscellaneous Expenses + 12.92 -14.31 -16.99 100 Less: Pre-operative Expenses Capitalised+ 0 0 0 Total Expenditure 68.41 45.76 31.94 100 Operating Profit 72.75 39.51 22.83 100 Interest + -62.69 -52.93 -77.73 100 Gross Profit 77.9 43.79 25.91 100 Depreciation+ 22.44 20.24 17.82 100 Profit Before Tax 93.43 50.39 28.17 100 Tax+ 146.73 81.45 62.06 100 Deferred Tax+ -210.01 -59.95 -158.63 100 Reported Net Profit 91.35 49.31 26.04 100 Extraordinary Items + 300 -500 -566.67 100 Adjusted Net Profit 91.36 49.71 26.46 100
Common Size Financial Statements
Balance Sheet
Year 2011 2010 2009 2008 2011 SOURCES OF FUNDS : Share Capital + 6.51 7.75 8.85 8.57 9.22 Reserves Total + 93.49 92,25 91.15 91.43 90.78 Total Shareholders Funds 100 100 100 100 100 Secured Loans + 0 0 0 0 0 Unsecured Loans + 0 0 0 0 0 Total Debt 0 0 0 0 0
Amrita School of Business 33
2012 [GSK CONSUMER HEALTHCARE]
Total Liabilities 100 100 100 100 100 APPLICATION OF FUNDS : Gross Block + 81.02 96.13 106.69 93.95 98.73 Less : Accumulated Depreciation + 46.05 49.81 49.24 37.26 32.98 Net Block + 34.97 46.32 57.45 56.69 65.75 Lease Adjustment 0 0 0 0 0 Capital Work in Progress+ 2.68 1.2 2.28 1.38 1.29 Investments + 46.08 40.48 0 0 0 Current Assets, Loans & Advances Inventories + 30.14 26.82 27.58 16.09 18.76 Sundry Debtors + 4.23 5.18 5.07 4.76 3.73 Cash and Bank+ 14.49 8.83 39.11 49.96 41.41 Loans and Advances + 95.47 101.4 98.48 92.55 89.6 Total Current Assets 144.34 142.23 170.24 163.37 153.51 Less : Current Liabilities and Provisions Current Liabilities + 34.09 34.68 37.17 32.06 34.36 Provisions + 91.31 91.11 87 83.34 81.46 Total Current Liabilities 125.39 125.79 124.16 115.39 115.82 Net Current Assets 18.95 16.44 46.08 47.97 37.68 Miscellaneous Expenses not written off + 0 0 0 0 1 Deferred Tax Assets 0.94 0.84 1.11 1.24 1.35 Deferred Tax Liability 3.61 5.28 6.92 7.28 7.08 Net Deferred Tax -2.67 -4.44 -5.81 -6.04 -5.72 Total Assets 100 100 100 100 100 Contingent Liabilities+ 0 0 5.79 4.21 4.18
Profit and Loss Account
YearDec 07(12)
Dec 06(12)
Dec 05(12)
INCOME : Sales Turnover + 106.70 109.14 112.90
Amrita School of Business 34
2012 [GSK CONSUMER HEALTHCARE]
Excise Duty 6.79.13919
812.8997
8 Net Sales 100.00 100.00 100
Other Income + 5.45.24507
45.09231
9
Stock Adjustments + -2.1-
0.129863.94986
5 Total Income 103.30 105.37 109.04 EXPENDITURE :
Raw Materials +27.3012
824.8049
826.1105
8
Power & Fuel Cost+2.39041
32.69919
32.83540
2
Employee Cost +11.7785
211.7554
211.9470
4
Other Manufacturing Expenses +14.8968
915.5746
916.2773
8 Selling and Administration Expenses +
25.34749 26.7322
27.52672
Miscellaneous Expenses +2.81368
3 2.452092.73069
4 Less: Pre-operative Expenses Capitalised+ 0 0 0
Total Expenditure 84.5384.0185
887.4278
2
Operating Profit23.0261
821.3563
621.6143
6
Interest +0.36201
70.31834
80.43749
2
Gross Profit22.6641
621.0380
121.1768
7
Depreciation+3.41521
33.85173
84.33863
1
Profit Before Tax19.2489
517.1862
716.8382
4
Tax+6.63410
35.60310
25.75270
3
Deferred Tax+-
0.53321-
0.31835-
0.45408
Reported Net Profit12.7750
511.4469
911.1083
5
Extraordinary Items +0.00942
3-
0.02164-
0.02903
Adjusted Net Profit12.7656
211.4686
411.1373
7
Amrita School of Business 35
2012 [GSK CONSUMER HEALTHCARE]
Recommendation
The current market scenario is a one with high market instability which is due
to high volatility and global slowdown. The effect of slowdown on the
consumer goods sector has been quite less compared to the other sectors. This
is a positive sign for the companies in this sector. Based on current market
performance of the company and the better performance expectation we
recommend the current share holders to HOLD the shares and the prospective
buyers to BUY the share. These recommendations are on the basis of following
factors.
1. Global slowdown: The effect of global slowdown has been quite less in the
consumer and healthcare sector as compared to other sectors. As a result the
demand for the products of the company has been steady even now. Also
Indian economy has been projected to be effected by a minimal scale. These
reasons indicate a higher growth prospectus for the company.
2. Ratio Analysis: The key ratios of the company are the leading indicators
about the company’s overall performance. Ratio analysis of the company have
indicated factors like healthy liquidity of the company , higher profitability,
healthier leverage margins and higher payout ratios which are good signs for
the company.
3. EPS and P/E Ratios: These ratios indicate the earnings for the share holders
and the market expectation about the company. The company has provided Amrita School of Business 36
2012 [GSK CONSUMER HEALTHCARE]
good returns to its investors and the P/E ratio is also attractive one for a retail
investor.
BIBLIOGRAPHY
www.gsk-ch.in
www.moneycontrol.com
www.myiris.com
www.marketingpractice.blogspot.com
www.economictimes.indiatimes.com
www.bseindia.com
www.capitaline.com
Amrita School of Business 37